These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 18803574)
1. To replace or not to replace: a systematic approach to respond to device advisories. Priori SG; Auricchio A; Nisam S; Yong P J Cardiovasc Electrophysiol; 2009 Feb; 20(2):164-70. PubMed ID: 18803574 [TBL] [Abstract][Full Text] [Related]
2. Complications associated with generator replacement in response to device advisories. Costea A; Rardon DP; Padanilam BJ; Fogel RI; Prystowsky EN J Cardiovasc Electrophysiol; 2008 Mar; 19(3):266-9. PubMed ID: 18081773 [TBL] [Abstract][Full Text] [Related]
3. Survival rates as a guide to implanted cardioverter-defibrillator replacement strategies for device recalls--adding statistical insight to clinical intuition. Gula LJ; Massel D; Krahn AD; Skanes AC; Yee R; Klein GJ Am Heart J; 2007 Feb; 153(2):253-9. PubMed ID: 17239686 [TBL] [Abstract][Full Text] [Related]
4. Complications of replacing implantable devices in response to advisories: a single center experience. Moore JW; Barrington W; Bazaz R; Jain S; Nemec J; Ngwu O; Schwartzman D; Shalaby A; Saba S Int J Cardiol; 2009 May; 134(1):42-6. PubMed ID: 18372058 [TBL] [Abstract][Full Text] [Related]
5. Should recent defibrillator and lead advisories affect decisions to refer patients for implantable cardioverter-defibrillator therapy? Amin MS; Ellenbogen KA Curr Opin Cardiol; 2010 Jan; 25(1):23-8. PubMed ID: 19907318 [TBL] [Abstract][Full Text] [Related]
15. Laser-assisted extraction of pacemaker and defibrillator leads: the role of the cardiac surgeon. Gaca JG; Lima B; Milano CA; Lin SS; Davis RD; Lowe JE; Smith PK Ann Thorac Surg; 2009 May; 87(5):1446-50; discussion 1450-1. PubMed ID: 19379883 [TBL] [Abstract][Full Text] [Related]
16. Appropriate evaluation and treatment of heart failure patients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock. Mishkin JD; Saxonhouse SJ; Woo GW; Burkart TA; Miles WM; Conti JB; Schofield RS; Sears SF; Aranda JM J Am Coll Cardiol; 2009 Nov; 54(22):1993-2000. PubMed ID: 19926003 [TBL] [Abstract][Full Text] [Related]
17. Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death. Stockburger M; Krebs A; Nitardy A; Habedank D; Celebi O; Knaus T; Dietz R Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S16-20. PubMed ID: 19250084 [TBL] [Abstract][Full Text] [Related]
18. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia. Hayashi M; Denjoy I; Extramiana F; Maltret A; Buisson NR; Lupoglazoff JM; Klug D; Hayashi M; Takatsuki S; Villain E; Kamblock J; Messali A; Guicheney P; Lunardi J; Leenhardt A Circulation; 2009 May; 119(18):2426-34. PubMed ID: 19398665 [TBL] [Abstract][Full Text] [Related]
19. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure. Spencker S; Coban N; Koch L; Schirdewan A; Müller D Europace; 2009 Apr; 11(4):483-8. PubMed ID: 19103654 [TBL] [Abstract][Full Text] [Related]
20. [Iatrogenic risk of permanent pacemaker and defibrillator implantation]. Bongiorni MG; Di Cori A; Soldati E; Zucchelli G; Segreti L; Solarino G; De Lucia R; Sergi D G Ital Cardiol (Rome); 2009 Jun; 10(6):395-406. PubMed ID: 19603611 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]